Agile_Logo-color on white.jpg
Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline
12 juil. 2016 16h12 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Cohera Medical, Inc.
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
12 juil. 2016 09h30 HE | Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Cascadian Therapeuti
Cascadian Therapeutics Receives ONT-380 Fast Track Designation from FDA for the Treatment of Advanced HER2+ Metastatic Breast Cancer
29 juin 2016 08h00 HE | Cascadian Therapeutics
SEATTLE, June 29, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic...
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend
21 juin 2016 11h30 HE | Industry Standard Research
CARY, NC--(Marketwired - June 21, 2016) - Industry Standard Research has released its comprehensive new report, "Phase II/III Study Trends and Market Outlook (2016-2020)," concerning the trends,...
Summit Master_rgb_png.png
Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection
20 juin 2016 12h30 HE | Summit Therapeutics PLC
Microbiome-Sparing Action of Ridinilazole associated with Superiority over Vancomycin in Sustained Clinical Response Rate OXFORD, United Kingdom, June 20, 2016 (GLOBE NEWSWIRE) -- Summit...
Summit Master_rgb_png.png
First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMD
17 juin 2016 07h00 HE | Summit Therapeutics PLC
OXFORD, United Kingdom, June 17, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular...
Achillion-Logo-150 (4).jpg
Achillion Presents Interim Phase 1 Results for ACH-4471, a Novel Orally-Administered Factor D Inhibitor, at the 21st Congress of the European Hematology Association
10 juin 2016 03h30 HE | Achillion Pharmaceuticals, Inc.
-  Results indicate up to 100% inhibition of alternative-pathway (AP) activity in hemolysis and Wieslab assays after oral dosing of ACH-4471  - -  Results support initiation...
Provista Diagnostics
Provista Diagnostics Announces Positive Trial Results Assessing the Use of Videssa® Breast to Detect Breast Cancer
02 juin 2016 08h00 HE | Provista Diagnostics, Inc.
NEW YORK, June 02, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women,...
Protalix BioTherapeutics to Present at the Jefferies 2016 Global Healthcare Conference
02 juin 2016 07h30 HE | Protalix BioTherapeutics, Inc.
CARMIEL, Israel, June 02, 2016 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today announced that Moshe Manor, the Company's President and Chief Executive...
CISCRP Medical Heroes Appreciation 5K Event Will Bring Together Research Professionals and the Public to Honor Clinical Trial Volunteers
24 mai 2016 08h35 HE | CISCRP
PHILADELPHIA, PA., May 24, 2016 (GLOBE NEWSWIRE) -- The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization, is excited to announce its...